Goldman Sachs Group Inc Pliant Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 475,877 shares of PLRX stock, worth $780,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares

475,877

Previous 475,877 -0.0%

Holding current value

$780,438

Previous $642,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$1.35 - $13.53 $39,388 - $394,764	29,177 Added 6.53%	475,877 $642,000
Q4 2024 Feb 11, 2025	BUY	$10.55 - $15.7 $1.05 Million - $1.56 Million	99,303 Added 28.58%	446,700 $5.88 Million
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $1.41 Million - $1.93 Million	134,159 Added 62.92%	347,397 $3.89 Million
Q2 2024 Aug 13, 2024	SELL	$10.58 - $15.61 $3.06 Million - $4.52 Million	-289,333 Reduced 57.57%	213,238 $2.29 Million
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $1.63 Million - $2.26 Million	115,325 Added 29.78%	502,571 $7.49 Million
Q4 2023 Feb 13, 2024	BUY	$12.85 - $19.15 $2.85 Million - $4.25 Million	222,132 Added 134.53%	387,246 $7.01 Million
Q3 2023 May 14, 2024	SELL	$14.58 - $20.15 $3.24 Million - $4.48 Million	-222,132 Reduced 57.36%	165,114 $2.86 Million
Q3 2023 Nov 14, 2023	SELL	$14.58 - $20.15 $888,053 - $1.23 Million	-60,909 Reduced 26.95%	165,114 $2.86 Million
Q2 2023 May 14, 2024	SELL	$18.12 - $30.56 $679,318 - $1.15 Million	-37,490 Reduced 14.23%	226,023 $4.1 Million
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $679,318 - $1.15 Million	-37,490 Reduced 14.23%	226,023 $4.1 Million
Q1 2023 May 14, 2024	BUY	$18.73 - $36.26 $2.18 Million - $4.21 Million	116,156 Added 78.83%	263,513 $7.01 Million
Q1 2023 May 11, 2023	BUY	$18.73 - $36.26 $2.18 Million - $4.21 Million	116,156 Added 78.83%	263,513 $7.01 Million
Q4 2022 May 14, 2024	BUY	$17.0 - $25.43 $761,447 - $1.14 Million	44,791 Added 43.67%	147,357 $2.85 Million
Q4 2022 Feb 13, 2023	BUY	$17.0 - $25.43 $761,447 - $1.14 Million	44,791 Added 43.67%	147,357 $2.85 Million
Q3 2022 May 14, 2024	SELL	$7.67 - $24.23 $2.52 Million - $7.96 Million	-328,658 Reduced 76.22%	102,566 $2.14 Million
Q3 2022 Nov 10, 2022	SELL	$7.67 - $24.23 $2.52 Million - $7.96 Million	-328,658 Reduced 76.22%	102,566 $2.14 Million
Q2 2022 May 14, 2024	BUY	$4.11 - $8.75 $180,749 - $384,807	43,978 Added 11.36%	431,224 $3.45 Million
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $1.19 Million - $2.52 Million	288,539 Added 202.22%	431,224 $3.45 Million
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $315,849 - $635,303	45,057 Added 46.15%	142,685 $1 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $792,175 - $1.18 Million	64,562 Added 195.25%	97,628 $1.32 Million
Q3 2021 Nov 10, 2021	BUY	$16.48 - $28.98 $544,927 - $958,252	33,066 New	33,066 $558,000

Others Institutions Holding PLRX

# of Institutions

154

Shares Held

62.2M

Call Options Held

279K

Put Options Held

7.1K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $79.8M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Pliant Therapeutics, Inc. Transaction History